Posted by Michael Wonder on 11 Aug 2019
US patients struggle to obtain Eli Lilly’s half-price insulin
11 August 2019 - Cheaper option was unveiled shortly before company was grilled by Congress about soaring prices.
US diabetes patients are struggling to obtain Eli Lilly’s half-price insulin, which it unveiled shortly before being grilled by Congress about the soaring price of the essential medicine.
Only about 3% of insurance claims for Eli Lilly’s insulin were for the cheaper, generic version Insulin Lispro, compared with 97% for its brand name Humalog, according to recent data from GoodRx, an app that tracks drug prices.
